#Coronary Intravascular Lithotripsy Market
Text
Breaking Barriers: The Thriving Coronary Intravascular Lithotripsy Market is Projected to Reach US$ 592.2 Million by 2033 at a CAGR of 6.2% Future Market Insights
The Coronary Intravascular Lithotripsy Market is experiencing a remarkable growth trajectory, transforming the landscape of cardiac care. This cutting-edge technology is making waves in the field of interventional cardiology, offering safer and more effective solutions for patients with calcified coronary artery disease.
Coronary artery disease, often complicated by calcified plaque buildup, presents a significant challenge in the treatment of heart conditions. Conventional treatments may struggle to penetrate and effectively treat these calcifications, leading to suboptimal outcomes. Enter Coronary Intravascular Lithotripsy, a game-changer in the world of cardiovascular interventions.
The epidural guidance systems market size is projected to be worth US$ 1.17 billion in 2023. The market is likely to surpass US$ 4.22 billion by 2033 at a CAGR of 13.7% during the forecast period. The market growth is being propelled by increased usage of computer-assisted navigation.
Download Sample Report to learn about recent in the Coronary Intravascular Lithotripsy Market observed by FMI @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17667
Key Benefits of Coronary Intravascular Lithotripsy Market :
Enhanced Patient Outcomes: Coronary IVL offers superior outcomes for patients with calcified coronary artery disease, reducing the risk of complications and improving overall quality of life.
Minimized Trauma: Unlike traditional methods, IVL minimizes trauma to healthy vessel tissue, reducing the risk of dissections and other complications during angioplasty.
Shorter Procedure Times: IVL simplifies complex procedures, leading to shorter operating times and less exposure to radiation for both patients and healthcare providers.
Reduced Restenosis Rates: By effectively treating calcified lesions, IVL reduces the likelihood of restenosis (re-narrowing of the artery), decreasing the need for repeat interventions.
Improved Access: It expands the possibility of treatment for patients who were previously considered high-risk due to severe calcification.
Market Growth and Future Prospects :
Increasing Incidence of Coronary Artery Disease: The global rise in heart-related diseases necessitates innovative treatments like IVL to address complex cases efficiently.
Technological Advancements: Ongoing research and development efforts are leading to the refinement of IVL systems, enhancing their effectiveness and safety.
Expanding Awareness: Healthcare providers and patients alike are becoming more aware of the benefits of IVL, leading to greater adoption.
Aging Population: With an aging global population, the prevalence of calcified coronary artery disease is expected to rise, further fueling market growth.
Key Players in the Coronary Intravascular Lithotripsy Industry :
Shockwave Medical, Inc.
The Coronary Intravascular Lithotripsy Market Takeaways and Projections
The U.S. is expected to lead The Coronary Intravascular Lithotripsy Market, projecting the fastest growth in the region between 2023-2033
Germany and the U.K. are expected to, collectively, hold the largest share in the Europe market over the assessment period.
China will dominate the East Asia market, accounting for the largest demand share during the forecast period.
India is expected to emerge as a highly remunerative market in South Asia, contributing the significant revenue share in the region through 2033.
Segmentation Analysis of the Coronary Intravascular Lithotripsy Market :
By Distribution Channel:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa
0 notes
Text
A Brighter Future for Autism Care: Global Intravascular Imaging Market
Join the revolution in medical technology as the intravascular imaging market skyrockets towards unprecedented growth With a projected worth of USD 387.8 million in 2023, this dynamic sector is poised to reach an impressive USD 656.29 million by 2033.
Experience the power of innovation as the market surges forward at a remarkable Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2023 to 2033. From cutting-edge imaging technologies to groundbreaking medical advancements, the potential for transformative impact is limitless.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9926
Key Highlights:
Advancements in Imaging Technology: Ongoing advancements in intravascular imaging technology, including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), are driving market growth and innovation. These imaging modalities provide detailed visualization of blood vessel anatomy, plaque morphology, and tissue composition, enabling precise diagnosis, treatment planning, and intervention guidance in cardiovascular procedures.
Clinical Benefits and Improved Patient Outcomes: Intravascular imaging technologies offer healthcare providers valuable diagnostic information and procedural guidance, leading to improved patient outcomes and reduced procedural complications. By providing real-time visualization of vascular structures and pathology, intravascular imaging facilitates accurate lesion assessment, stent sizing, and optimization of treatment strategies, enhancing the safety and efficacy of cardiovascular interventions.
Expansion of Indications and Applications: The expanding indications and applications of intravascular imaging technologies across a wide range of cardiovascular conditions, including coronary artery disease, peripheral vascular disease, and structural heart disorders, are driving market growth. Advances in catheter design, imaging software, and data analysis algorithms are expanding the utility and versatility of intravascular imaging solutions in clinical practice.
Focus on Minimally Invasive Interventions: The shift towards minimally invasive cardiovascular interventions is driving the demand for intravascular imaging technologies that enable precise lesion characterization and treatment planning. Intravascular imaging-guided procedures such as percutaneous coronary intervention (PCI), intravascular lithotripsy (IVL), and transcatheter valve replacement (TAVR) offer patients safer, more effective alternatives to traditional open surgeries, driving market adoption and growth.
Key Takeaways:
The United States is predicted to reach US$ 700 million by 2033.
The United States is predicted to increase at a 5.6% annual rate.
The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.
China’s intravascular imaging industry is anticipated to be worthUS$850 million.
The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.
“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.
Competitive Landscape:
In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.
Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.
Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.
Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.
Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.
Segmentation Analysis of the intravascular imaging Market
By Product Type:
Instruments
Software
By Modality:
Handheld
Trolley Mounted
By End User:
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Long Term Care Centers
Others
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa
0 notes
Text
Japan approves Shockwave Medical’s C² Coronary IVL Catheter
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has given endorsement to Shockwave Medical's Shockwave C² Coronary Intravascular Lithotripsy (IVL) Catheter.
The administrative endorsement was upheld by 30-day results acquired from the planned, multicentre Disrupt CAD IV review.
In the review, the Shockwave C² Coronary IVL Catheter's security and viability were assessed in 64 Japanese patients.
Shockwave Medical noticed that the gadget met the essential security endpoint - independence from major unfriendly cardiac catheters market occasions (MACE) at 30 days. It likewise met the viability endpoint with a pace of 93.8%.
The discoveries from the review were predictable with the information acquired from the Disrupt CAD III preliminary.
As far as the security part of the gadget, there were no unexpected terminations, holes or slow/no-reflow occasions noted whenever during the systems.
All members of the Disrupt CAD IV review got intravascular imaging, which uncovered last stent results of a base stent area of 5.7mm² and stent extension at the most extreme calcification site of 99.5%.
Shockwave Medical CEO Doug Godshall said: "We are glad to band together with the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) to make this treatment accessible to the master cardiologists in Japan.
"We are sure that CVIT will be the ideal accomplice to assist with guaranteeing that coronary IVL will assume a fundamental part later on calcium treatment calculations of Japanese doctors."
Last year, the Shockwave C² coronary IVL catheter got premarket endorsement (PMA) from the US Food and Drug Administration (FDA). It likewise got CE Mark in 2018.
At present, the organization is anticipating repayment endorsement from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the gadget.
0 notes
Text
Lithotripsy Market report offering latest trend, research mythology, segmentation, types with latest innovation.
Overview:
Lithotripsy is a medical procedure which involves breaking stones present in the bladder, kidney, and ureter into tiny pieces through the use of high-energy shock waves so that they can be easily passed through the urine. Lithotripsy is the most common line of treatment for kidney stones. The global lithotripsy market is anticipated to capture a moderate CAGR of 4.1 % over the forecast period. The global lithotripsy market is likely to attain USD 524.9 Mn by the end of 2023.
The growing prevalence of urological disorders is one of the main factors boosting the growth of the global lithotripsy market. Additionally, one of the main advantages associated with lithotripsy is that it does not involve any incision. Growing preference for minimally -invasive and noninvasive medical procedures is a prime factor augmenting the growth of the market.
Report Details @ https://www.marketresearchfuture.com/reports/lithotripsy-market-3200
Increasing investment by market players on the development of novel devices and innovation has resulted in various product launches which are expected to augur market growth over the forecast period. Other factors fostering market growth include improvement in reimbursement scenario, the rise in the aging population, and spreading awareness regarding the procedure.
However, very large stones cannot be treated with lithotripsy and lithotripsy is not suitable for every patient who might impede the growth of the market over the forecast period. Moreover, lithotripsy is not suitable for pregnant women, people with bleeding disorders, morbidly obese people, and people with severe skeletal abnormalities. The underlying potential risk of causing injuries to the kidney is also a factor which restricts patients to opt for the procedure. However, advancements in technology and innovation in procedures is likely to present growth opportunities to the global lithotripsy market.
Segmentation
The global lithotripsy market has been segmented based on type and end user.
By type, the global lithotripsy market has been segmented into extracorporeal shock wave lithotripsy (ESWL), intracorporeal (endoscopic lithotripsy), percutaneous lithotripsy, and others. The intracorporeal segment has been segmented into laser lithotripsy, electrohydraulic lithotripsy, mechanical lithotripsy, and ultrasonic lithotripsy.
By end user, the global lithotripsy market has been segmented into hospitals and clinics, research laboratories, academic institutes, and others.
Regional Analysis
By region, the global lithotripsy market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas is the largest market for lithotripsy and held the largest share of the market in 2016. The widespread prevalence of urology disorders and the presence of a massive pool of diabetic patients in the region drive the Americas market. Moreover, robust healthcare sector, favorable reimbursement scenario, and high healthcare expenditure in the region can be credited for the growth of the market.
Europe commands the second position in the global lithotripsy market where Western Europe accounts for the lion's share of the market. High healthcare expenditure and spreading awareness about new products and therapies in the region can be credited for the growth of the market.
APAC is the fastest growing market for lithotripsy. Expanding healthcare sector, improving reimbursement scenario and the existence of a broad patient base in the region stimulates the growth of the market. The MEA market is expected to grow at a moderate pace over the forecast period.
Competitive Landscape
EDAP TMS (France), Boston Scientific (US), Medispec LTD (US), Dornier MedTech.(Germany), Siemens Healthcare GmbH (Germany), STORZ MEDICAL AG (Switzerland), DIREX, S.L. (Spain), Elmed Electronics & Medical Industry & Trade Inc.(Turkey), Jena Med Tech GmbH (Germany), Olympus Corporation (Japan) are the key players in the global lithotripsy market.
Industry Updates
In December 2018, Shockwave Medical, a company specializing in the development and commercialization of intravascular lithotripsy, announced a partnership with Abiomed, Inc., a manufacturer of medical implant devices. The companies have collaborated for the purpose of a training and education program in the US and Germany with a prime focus on their respective technologies.
In May 2018, Shockwave Medical, a pioneer of Intravascular Lithotripsy launched Coronary Intravascular Lithotripsy in Europe.
Ref:https://www.medgadget.com/2019/07/lithotripsy-market-2019-global-segments-profit-growth-size-share-and-business-trends-by-forecast-to-2023.html
0 notes
Text
Shockwave Medical sets terms for $75m IPO
Shockwave Medical this week set terms for its initial public offering, looking to bring in approximately $75 million, according to an SEC filing.
The Santa Clara, Calif.-based company said that it plans to float approximately 5 million shares of its common stock at a price between $14 and $16, according to the filing.
The IPO will also include an underwriter’s option to purchase an additional 750,000 shares of stock at the same price, which could bring in an additional $11.3 million for the company. The company could bring in as much as $92 million with a fully-exercised underwriter’s option if shares are offered at the top-end of the range, according to the filing.
Shockwave Medical said that certain existing investors will receive options to purchase up to an aggregate of approximately $10.5 million in common stock in a concurrent private placement at the same price as the IPO, according to an SEC filing.
The company is looking to list its common stock on the Nasdaq Global Market under the symbol “SWAV,” according to the filing.
Net proceeds from the offering are slated to support ongoing commercialization of the company’s Intravascular Lithotripsy, or IVL, devices. Funds will also be used to expand the company’s sales force, medical affairs teams and educational efforts, as well as for possible strategic transactions and for general corporate purposes.
Shockwave Medical has not yet set a date for the offering.
Last month, Shockwave Medical said that it launched a U.S. pivotal trial for its coronary lithotripsy device, which is designed to prepare heavily calcified coronary lesions for stenting.
The post Shockwave Medical sets terms for $75m IPO appeared first on MassDevice.
from MassDevice https://ift.tt/2TrvjaC
0 notes
Text
Breaking Barriers: The Thriving Coronary Intravascular Lithotripsy Market is Projected to Reach US$ 592.2 Million by 2033 at a CAGR of 6.2% Future Market Insights
The Coronary Intravascular Lithotripsy Market is experiencing a remarkable growth trajectory, transforming the landscape of cardiac care. This cutting-edge technology is making waves in the field of interventional cardiology, offering safer and more effective solutions for patients with calcified coronary artery disease.
Coronary artery disease, often complicated by calcified plaque buildup, presents a significant challenge in the treatment of heart conditions. Conventional treatments may struggle to penetrate and effectively treat these calcifications, leading to suboptimal outcomes. Enter Coronary Intravascular Lithotripsy, a game-changer in the world of cardiovascular interventions.
The epidural guidance systems market size is projected to be worth US$ 1.17 billion in 2023. The market is likely to surpass US$ 4.22 billion by 2033 at a CAGR of 13.7% during the forecast period. The market growth is being propelled by increased usage of computer-assisted navigation.
Download Sample Report to learn about recent in the Compound Feed industry observed by FMI @
https://www.futuremarketinsights.com/reports/sample/rep-gb-17667
Key Benefits of Coronary Intravascular Lithotripsy Market :
Enhanced Patient Outcomes: Coronary IVL offers superior outcomes for patients with calcified coronary artery disease, reducing the risk of complications and improving overall quality of life.
Minimized Trauma: Unlike traditional methods, IVL minimizes trauma to healthy vessel tissue, reducing the risk of dissections and other complications during angioplasty.
Shorter Procedure Times: IVL simplifies complex procedures, leading to shorter operating times and less exposure to radiation for both patients and healthcare providers.
Reduced Restenosis Rates: By effectively treating calcified lesions, IVL reduces the likelihood of restenosis (re-narrowing of the artery), decreasing the need for repeat interventions.
Improved Access: It expands the possibility of treatment for patients who were previously considered high-risk due to severe calcification.
Market Growth and Future Prospects :
Increasing Incidence of Coronary Artery Disease: The global rise in heart-related diseases necessitates innovative treatments like IVL to address complex cases efficiently.
Technological Advancements: Ongoing research and development efforts are leading to the refinement of IVL systems, enhancing their effectiveness and safety.
Expanding Awareness: Healthcare providers and patients alike are becoming more aware of the benefits of IVL, leading to greater adoption.
Aging Population: With an aging global population, the prevalence of calcified coronary artery disease is expected to rise, further fueling market growth.
Key Players in the Coronary Intravascular Lithotripsy Industry :
Shockwave Medical, Inc.
The Coronary Intravascular Lithotripsy Market Takeaways and Projections
The U.S. is expected to lead The Coronary Intravascular Lithotripsy Market, projecting the fastest growth in the region between 2023-2033
Germany and the U.K. are expected to, collectively, hold the largest share in the Europe market over the assessment period.
China will dominate the East Asia market, accounting for the largest demand share during the forecast period.
India is expected to emerge as a highly remunerative market in South Asia, contributing the significant revenue share in the region through 2033.
Segmentation Analysis of the Coronary Intravascular Lithotripsy Market :
By Distribution Channel:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa
0 notes
Text
Unlocking Potential: How Technology is Transforming the Global Intravascular Imaging Market
The global intravascular imaging market would be valued US$ 387.8 million by 2023. By 2033, the market is probably going to reach US$ 656.29 million. The market is anticipated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2033.
Intravascular imaging technologies are essential for the diagnosis and treatment of cardiovascular illnesses because they provide important information on the anatomy and physiology of blood vessels to medical professionals. The need for intravascular imaging solutions is anticipated to increase as the prevalence of cardiovascular conditions, including diabetes and hypertension, atherosclerosis, and coronary artery disease, continues to rise globally due to factors like aging populations, sedentary lifestyles, and rising rates of risk factors like these.
Claim Your Exclusive Report Sample Preview:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9926
Key Highlights:
Advancements in Imaging Technology: Ongoing advancements in intravascular imaging technology, including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), are driving market growth and innovation. These imaging modalities provide detailed visualization of blood vessel anatomy, plaque morphology, and tissue composition, enabling precise diagnosis, treatment planning, and intervention guidance in cardiovascular procedures.
Clinical Benefits and Improved Patient Outcomes: Intravascular imaging technologies offer healthcare providers valuable diagnostic information and procedural guidance, leading to improved patient outcomes and reduced procedural complications. By providing real-time visualization of vascular structures and pathology, intravascular imaging facilitates accurate lesion assessment, stent sizing, and optimization of treatment strategies, enhancing the safety and efficacy of cardiovascular interventions.
Expansion of Indications and Applications: The expanding indications and applications of intravascular imaging technologies across a wide range of cardiovascular conditions, including coronary artery disease, peripheral vascular disease, and structural heart disorders, are driving market growth. Advances in catheter design, imaging software, and data analysis algorithms are expanding the utility and versatility of intravascular imaging solutions in clinical practice.
Focus on Minimally Invasive Interventions: The shift towards minimally invasive cardiovascular interventions is driving the demand for intravascular imaging technologies that enable precise lesion characterization and treatment planning. Intravascular imaging-guided procedures such as percutaneous coronary intervention (PCI), intravascular lithotripsy (IVL), and transcatheter valve replacement (TAVR) offer patients safer, more effective alternatives to traditional open surgeries, driving market adoption and growth.
Key Takeaways:
The United States is predicted to reach US$ 700 million by 2033.
The United States is predicted to increase at a 5.6% annual rate.
The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.
China’s intravascular imaging industry is anticipated to be worthUS$850 million.
The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.
“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.
Competitive Landscape:
In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.
Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.
Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.
Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.
Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.
Segmentation Analysis of the intravascular imaging Market
By Product Type:
Instruments
Software
By Modality:
Handheld
Trolley Mounted
By End User:
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Long Term Care Centers
Others
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa
0 notes
Text
Shockwave Medical registers for $70m IPO
Shockwave Medical has registered for an upcoming initial public offering worth $70 million, according to recently posted SEC filings.
The Santa Clara, Calif.-based vascular tech developer is looking to list its common stock on the Nasdaq Global Market under the symbol “SWAV,” according to the filing.
Net proceeds from the offering are slated to support ongoing commercialization of the company’s Intravascular Lithotripsy, or IVL, devices, according to the filing. Funds will also be used to expand the company’s sales force, medical affairs teams and educational efforts, as well as for possible strategic transactions and for general corporate purposes.
Shockwave Medical has not yet stated how many shares it plans to offer in the round or the pricing for the shares.
Last month, Shockwave Medical said that it launched a U.S. pivotal trial for its coronary lithotripsy device, which is designed to prepare heavily calcified coronary lesions for stenting.
The post Shockwave Medical registers for $70m IPO appeared first on MassDevice.
from MassDevice http://bit.ly/2GDYbG3
0 notes
Last Seen Blogs
